REVA Medical
PrivateLast Round
Series B
Aug 9, 2022
Est. Valuation
$345M
Total Funding Raised
$112M
Company Overview
REVA Medical is a medical device company that develops and commercializes bioresorbable polymer technologies for vascular applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
REVA Medical Comparables
Compare REVA Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| R3 Vascular Inc. | 89% | |
| Elixir Medical Corporation | 88% | |
| Micro Medical Solutions | 83% |
REVA Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 9, 2022 | ||||
| Debt | Jan 14, 2020 | ||||
| Debt | Mar 24, 2019 | ||||
| Convertible Debt | Jun 16, 2017 | ||||
| Convertible Debt | Nov 20, 2014 | ||||
IPO | Dec 21, 2010 |
REVA Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elliott Investment Management L.P. | Debt |
| Domain Associates | Private Placement |
| Pequot Capital Management | Private Placement |
| Boston Scientific Corporation | Private Placement, Series B |
| Taylor Collison Limited | IPO |
| Goldman Sachs International | Debt |
| Brookside Capital Partners | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 9, 2022
$45M round led by Boston Scientific Corporation
- Jan 14, 2020
Secured $4.4M in debt financing from Elliott Investment Management and Goldman Sachs.
Recent news
Latest coverage and updates
- attends_eventOct 6, 2026
REVA Medical, LLC attends the VIVA26 congress on Oct 6th '26, where a live case demonstration and recent MOTIV study results highlight its bioresorbable scaffold technology.
- attends_eventOct 6, 2026
REVA Medical, LLC attends the Vascular InterVentional Advances (VIVA) 2026 conference in Nevada on Oct 6th '26, where it announces a live case demonstration with the MOTIV® bioresorbable vascular scaffold and the presentation of late-breaking MOTIV BTK trial results.
REVA Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about REVA Medical's valuation, stock price, and market status.
Is REVA Medical a public or private company?
REVA Medical is a private company.
What is the current stock price of REVA Medical?
REVA Medical is a private company, so its shares have no public market price. Caplight tracks REVA Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is REVA Medical worth (valuation)?
REVA Medical's valuation is estimated at $345.0M based on funding round data.
Can I buy REVA Medical stock?
REVA Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was REVA Medical's last funding round?
REVA Medical's most recent funding round was Series B on August 9, 2022.
Who are the main investors in REVA Medical?
Key investors in REVA Medical include Boston Scientific Corporation, Brookside Capital Partners, Cerberus Capital Management.
Will REVA Medical IPO soon?
No public IPO plans have been announced for REVA Medical.
How can I track REVA Medical secondary market activity?
Caplight tracks bids, offers, and trades in REVA Medical's shares on secondary markets.